Heads up if you use GLP-1 injections, especially ones from compounding pharmacies. On September 24, Apothecary Pharma LLC of ...
The Healthy @Reader's Digest on MSN
Blood pressure drug recall: More than 21,000 bottles involved nationwide
FDA officials says there's a chance that the medication could contain a "superpotent" element. Here's what that means for you ...
The compounded GLP-1s are not FDA-approved nor name-brand.
Wedgewood Pharmacy LLC is voluntarily recalling nearly 4000 compounded veterinary products that may contain too much or too little of their active ingredients. 1,2 The count refers to individual ...
Apothecary Pharma is recalling 23 vials of compounded injectable drugs distributed nationwide because their sterility cannot be assured, according to the Food and Drug Administration.
A company is recalling some compounded veterinary medications over concerns that some products are weaker or stronger than intended.
The Food and Drug Administration announced a voluntary nationwide recall of more than 4.3 million tubes of fluoride toothpaste.
More than 112,000 bottles of the medication is being recalled, according to the U.S. Food and Drug Administration.
Novartis Pharmaceuticals Corporation recalled some heart failure and high blood pressure medication due to potency issues, according to the Food and Drug Administration’s website. The recall affects ...
The FDA said they had been functioning as "subpotent drugs," meaning they had less of an active ingredient and were ultimately less effective. Major Pharmaceuticals packaged and distributed the ...
The FDA officially warned patients not to use compounded GLP-1s this month unless an individual’s medical needs cannot be met ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results